Differentiation induction therapy of myelodysplastic syndromes
- 31 December 1989
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 13 (7) , 633-637
- https://doi.org/10.1016/0145-2126(89)90133-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The myelodysplastic syndromesClinical and Laboratory Haematology, 2008
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Treatment of patients with myelodysplastic syndromes: A reviewScandinavian Journal of Haematology, 1986
- Preleukaemia: A long‐term prospective study of 326 patientsScandinavian Journal of Haematology, 1986
- Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.Journal of Clinical Pathology, 1985
- Myelodysplastic syndromes: a study of 101 cases according to the FAB classificationBritish Journal of Haematology, 1985
- Myelodysplastic syndromes. A clinical and pathologic analysis of 109 casesCancer, 1985
- Low Doses of Cytarabine in the Treatment of Myelodysplastic Syndrome and Acute Myeloid LeukemiaNew England Journal of Medicine, 1983
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983